Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.
about
Heat shock protein 70-mediated sensitization of cells to apoptosis by Carboxyl-Terminal Modulator ProteinThe adenovirus genome contributes to the structural stability of the virionSPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131IAdenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of CancerAn adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.Production of adenovirus vectors and their use as a delivery system for influenza vaccines.Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35.Tumor associated stromal cells play a critical role on the outcome of the oncolytic efficacy of conditionally replicative adenovirusesRestricting expression prolongs expression of foreign genes introduced into animals by retroviruses.Adeno-associated virus vectors and hematologyGene transfer for cystic fibrosisEfficient gene transfer into human CD34(+) cells by a retargeted adenovirus vectorImplication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organsEffects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeatsThe promise and potential hazards of adenovirus gene therapy.A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cellsImpact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines.Optimization of the helper-dependent adenovirus system for production and potency in vivo.Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.Vaccination with Human Induced Pluripotent Stem Cells Creates an Antigen-Specific Immune Response Against HIV-1 gp160.Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation.Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver.The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors.Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver.An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene.Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboonsChromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells.A rapid Q-PCR titration protocol for adenovirus and helper-dependent adenovirus vectors that produces biologically relevant results.Inhibition of NF-kappaB activation in combination with bcl-2 expression allows for persistence of first-generation adenovirus vectors in the mouse liverHuman adenovirus type 5 vectors deleted of early region 1 (E1) undergo limited expression of early replicative E2 proteins and DNA replication in non-permissive cells.Adenovirus virion stability and the viral genome: size mattersMutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors.Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs.Efficient, repeated adenovirus-mediated gene transfer in mice lacking both tumor necrosis factor alpha and lymphotoxin alpha.Dependence of adenovirus infectivity on length of the fiber shaft domain.Nuclear import of moloney murine leukemia virus DNA mediated by adenovirus preterminal protein is not sufficient for efficient retroviral transduction in nondividing cells.
P2860
Q24314764-108F4412-4D36-4A3F-A3EB-0220D4775065Q26825101-79A7118E-96E3-41C8-984C-64498F160701Q27307734-E674AB09-90E2-4A00-9EFC-3C7DAED7FB18Q27317286-F9D886C2-6724-44F1-A1EA-887AA6B16B3BQ27469506-D19729D5-67AC-4718-B296-589C7B65BFC8Q30226988-75422F7E-F51B-445F-A962-5AB1116AB5E3Q33381618-93CC4002-D1B2-4055-8E0D-41209D7653D3Q33425253-D049B231-6C9B-4AAB-BDDF-757F33B5BBC9Q33603763-91D31146-BE75-4D1C-A10E-647540ABCE04Q33695816-31AE4737-F1CD-483A-8946-B93A0F5970DEQ33764354-774FC437-9876-4090-8F76-D825ABE91AE3Q33799667-0D247875-06C9-448A-AD94-0F15BB32B577Q33813779-C4770345-1808-41BB-A9A9-93B95FD53352Q33815920-00BDF9EF-673C-435F-923C-1A16CEDB758EQ33817535-6BE127D9-3003-4B77-AE59-B47267369DF8Q33818929-731699FA-4667-401D-BCF8-8659B0E1F1B6Q33823132-27EDED94-EB9C-438E-855C-868412D375B5Q34219407-08DADEDE-4752-4FCF-A799-C59CF035D6DAQ34329158-780AFF5D-A8A5-417C-9024-6EEFB7120BFBQ34658351-71C2A5C2-CF51-434E-AF7A-098D2AAD8560Q34996749-63DE9DC0-90E9-4826-AC77-EBE82CA4169EQ35006603-3C153B2B-5659-4EBA-873F-12A92B772D8EQ35028679-4EE25A7B-8F76-489D-AF43-79ADB5A0078DQ35664973-74515D37-9C41-416E-A63D-2F4AF840EFC3Q35895708-BBB54C61-420B-42F0-AA54-62CAA7E20E8FQ35899034-BC16FBE2-414D-4CC7-A184-7A75624C2C9DQ36145287-703C2FDD-E149-4AD3-8303-9E874C846210Q36163092-96A08589-874C-4BD7-8171-349D0037273BQ36310768-0D03AF4D-51D3-465F-B3E0-BA50B3EDB0E8Q36557727-4AAEB582-7814-401F-BA40-1E30D90E2B91Q36867065-C0ABE80A-37FB-4109-A96C-B8B4E7551A24Q36920480-0CD4D6F6-3F64-4DEF-9C71-CFE4FDD147C3Q38332622-E0306F49-1F35-40EB-957E-3D4B3A91D6B6Q38682348-110B657D-8244-4B5B-9315-FA1F8ECB161BQ39502223-B688E2B7-ADD5-4F81-ADB8-74796565C156Q39549432-219645DB-F72F-4F16-8C27-B930E11C33CFQ39582614-CE65CB0C-EFAB-4A08-8AB1-E7691FD33BA7Q39582787-FBBDBF4E-447D-4044-B1C8-FC58A8EA3FA7Q39585255-04A72222-7EAB-417D-AB07-E376B9A1880AQ39588920-9FA8DF6A-30DE-4BA1-8671-04ACAA93762E
P2860
Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Recombinant adenoviruses with ...... vectors in vitro and in vivo.
@ast
Recombinant adenoviruses with ...... vectors in vitro and in vivo.
@en
type
label
Recombinant adenoviruses with ...... vectors in vitro and in vivo.
@ast
Recombinant adenoviruses with ...... vectors in vitro and in vivo.
@en
prefLabel
Recombinant adenoviruses with ...... vectors in vitro and in vivo.
@ast
Recombinant adenoviruses with ...... vectors in vitro and in vivo.
@en
P2093
P2860
P1433
P1476
Recombinant adenoviruses with ...... vectors in vitro and in vivo.
@en
P2093
P2860
P304
P407
P577
1996-12-01T00:00:00Z